Literature DB >> 11491200

Clinical manifestations of myocardial stunning.

G Ambrosio1, I Tritto.   

Abstract

The phenomenon of myocardial stunning has been observed in all animal species studied. The possible occurrence of myocardial stunning in man has been demonstrated after either regional ischemia (such as exercise-induced angina, vasospastic or unstable angina) or after global ischemia (i.e., after cardioplegic arrest during cardiac surgery, or cardiac arrest, or heart transplantation). Finally, it may also be observed in patients with acute myocardial infarction, subjected to recanalization therapy, because viable myocardium, salvaged by reperfusion, may remain stunned, with delayed contractile recovery. Occurrence of stunning may aggravate hemodynamic conditions in already unstable patients, and it may lead to underestimation of the extent of myocardium salvaged by thrombolysis. Repeated episodes of stunning may lead to a condition of apparently 'chronic' contractile dysfunction that may be difficult to differentiate from hibernation, because of the technical difficulties in accurately measuring myocardial blood flow in patients, and because both phenomena may coexist and overlap in the same patient. In addition, recent evidence suggests that repeated episodes of stunning may lead to a progressive worsening of the residual contractile dysfunction and to longer recovery times, and it has thus been suggested, and it is much debated, that hibernation might at least in part be the consequence of repetitive episodes of stunning.

Entities:  

Mesh:

Year:  2001        PMID: 11491200     DOI: 10.1097/00019501-200108000-00004

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  6 in total

1.  Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury.

Authors:  Neel R Sodha; Richard T Clements; Jun Feng; Yuhong Liu; Cesario Bianchi; Eszter M Horvath; Csaba Szabo; Gregory L Stahl; Frank W Sellke
Journal:  J Thorac Cardiovasc Surg       Date:  2009-06-13       Impact factor: 5.209

Review 2.  Targeting phosphodiesterase 5 as a therapeutic option against myocardial ischaemia/reperfusion injury and for treating heart failure.

Authors:  Sevil Korkmaz-Icöz; Tamás Radovits; Gábor Szabó
Journal:  Br J Pharmacol       Date:  2017-03-23       Impact factor: 8.739

3.  Is hyperglycemia bad for the heart during acute ischemia?

Authors:  Louis M Chu; Robert M Osipov; Michael P Robich; Jun Feng; Shizu Oyamada; Cesario Bianchi; Frank W Sellke
Journal:  J Thorac Cardiovasc Surg       Date:  2010-06-12       Impact factor: 5.209

Review 4.  Cardioprotection in stunned and hibernating myocardium.

Authors:  Christophe Depre; Stephen F Vatner
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

Review 5.  Toll-like receptor and its roles in myocardial ischemic/reperfusion injury.

Authors:  Yu Fang; Jianguo Hu
Journal:  Med Sci Monit       Date:  2011-04

Review 6.  Hyperkalemic cardioplegia for adult and pediatric surgery: end of an era?

Authors:  Geoffrey P Dobson; Giuseppe Faggian; Francesco Onorati; Jakob Vinten-Johansen
Journal:  Front Physiol       Date:  2013-08-28       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.